Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Doyle

Showing results (571-580 of 617) with videos related to

Pageof 62
Sort By:
Veterinary Surgery : VS|May 22, 2019
Intraoperative and major postoperative complications and survival of dogs undergoing surgical management of epiglottic retroversion: 50 dogs (2003-2017)Ronan A Mullins, Bryden J Stanley, James A Flanders, et al.
Sexually Transmitted Infections|June 20, 2024
Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance dataBrendan L Harney, Rachel Sacks-Davis, Michael Traeger, et al.
Frontiers in Immunology|February 29, 2024
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapyAnna C Hearps, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, et al.
Journal of the International AIDS Society|April 11, 2018
Linkage and retention in HCV care for HIV-infected populations: early data from the DAA eraRachel Sacks-Davis, Joseph S Doyle, Andri Rauch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis CJim Young, Shouao Wang, Rachel Sacks-Davis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 11, 2023
Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta-analysisStephanie C Munari, Michael W Traeger, Vinay Menon, et al.
Journal of Viral Hepatitis|June 20, 2022
Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugsMichael W Traeger, Daniela K van Santen, Rachel Sacks-Davis, et al.
Trials|July 18, 2018
Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trialA J Wade, J S Doyle, E Gane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2019
Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject DrugsAmanda J Wade, Joseph S Doyle, Edward Gane, et al.
Journal of Viral Hepatitis|July 6, 2026
Monitoring of the Cascade of Care in Patients With Chronic HBV in Primary Care Clinics in AustraliaDina Moussa, Jack Wallace, Jacqui Richmond, et al.
Pageof 62

Showing results (571-580 of 617) with videos related to

Sort By:
Pageof 62
Veterinary Surgery : VS|May 22, 2019
Intraoperative and major postoperative complications and survival of dogs undergoing surgical management of epiglottic retroversion: 50 dogs (2003-2017)Ronan A Mullins, Bryden J Stanley, James A Flanders, et al.
Sexually Transmitted Infections|June 20, 2024
Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance dataBrendan L Harney, Rachel Sacks-Davis, Michael Traeger, et al.
Frontiers in Immunology|February 29, 2024
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapyAnna C Hearps, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, et al.
Journal of the International AIDS Society|April 11, 2018
Linkage and retention in HCV care for HIV-infected populations: early data from the DAA eraRachel Sacks-Davis, Joseph S Doyle, Andri Rauch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis CJim Young, Shouao Wang, Rachel Sacks-Davis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 11, 2023
Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta-analysisStephanie C Munari, Michael W Traeger, Vinay Menon, et al.
Journal of Viral Hepatitis|June 20, 2022
Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugsMichael W Traeger, Daniela K van Santen, Rachel Sacks-Davis, et al.
Trials|July 18, 2018
Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trialA J Wade, J S Doyle, E Gane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2019
Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject DrugsAmanda J Wade, Joseph S Doyle, Edward Gane, et al.
Journal of Viral Hepatitis|July 6, 2026
Monitoring of the Cascade of Care in Patients With Chronic HBV in Primary Care Clinics in AustraliaDina Moussa, Jack Wallace, Jacqui Richmond, et al.
Pageof 62